Press release
Rising Incidence Of Brain Tumors Fuels Growth In The Adult Malignant Glioma Therapeutics Market: An Emerging Driver Transforming The Adult Malignant Glioma Therapeutics Market Landscape
Adult Malignant Glioma Therapeutics
What Is the Projected Growth of the Adult Malignant Glioma Therapeutics Market?
Recent years have seen a swift expansion in the market size for adult malignant glioma therapeutics. The market is projected to swell from $2.25 billion in 2024 to $2.48 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.4%. Factors fueling the growth during the past period include the escalating incidence rates, initiatives championing patient advocacy, and the deployment of personalized medical strategies.
The market size for adult malignant glioma treatments is predicted to witness considerable expansion in the upcoming years. It is anticipated to reach $3.55 billion by 2029, with a compound annual growth rate (CAGR) of 9.4%. This growth during the projected period can be credited to enhancements in immunotherapy, targeted therapies, the discovery of biomarkers, the application of liquid biopsies, and wider access programs. Key trends during this period encompass drug development centered around the patient, fast-tracking and breakthrough designations, progress in drug delivery systems, collective research efforts, and the utilization of artificial intelligence.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13178
What Are the Different Adult Malignant Glioma Therapeutics Market Segments?
The adult malignant glioma therapeutics market covered in this report is segmented -
1) By Type Of Disease: Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma, Other Types
2) By Therapy: Chemotherapy, Targeted Therapy, Radiotherapy, Other Therapies
3) By End-User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers, Other End Users
Subsegments:
1) By Glioblastoma Multiforme: Standard Treatments, Experimental Therapies
2) By Anaplastic Astrocytoma: Chemotherapy Options, Targeted Therapies
3) By Anaplastic Oligodendroglioma: Radiation Therapy, Combination Therapies
4) By Anaplastic Oligoastrocytoma: Surgical Interventions, Adjuvant Therapies
5) By Other Types: Rare Gliomas, Emerging Therapies
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13178&type=smp
What Are the Primary Drivers Shaping the Adult Malignant Glioma Therapeutics Market?
The rise in brain tumor incidents is anticipated to propel the adult malignant glioma therapeutics market. Brain tumors are abnormal tissue masses where the normal regulation mechanisms of cells seem not to influence their unchecked growth and multiplication. Adult malignant glioma is a brain tumor form that consists of abnormally and uncontrollably expanding cells. The treatment for Adult malignant glioma utilizes a combination of surgery, radiation therapy, and chemotherapy to eradicate brain tumors. For example, data from the American Cancer Society, a nonprofit cancer advocacy organization in the US, indicated an increased number of brain and nervous system cancer cases to 24,810 in 2023 from 23,890 in 2020, equating to a 3.85% growth rate. Consequently, the amplified incidents of brain tumors are steering growth in the adult malignant glioma therapeutics market. Adult Malignant Glioma Therapeutics Market Driver: Boost in Adult Malignant Glioma Therapeutics due to Government Funding
Which Companies Are Leading in the Adult Malignant Glioma Therapeutics Market?
Major companies operating in the adult malignant glioma therapeutics market report are Johnson & Johnson Private Limited, Pfizer Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Allergan PLC, AbbVie Inc., Novartis AG, Bayer AG, Merck & Co Inc., GlaxoSmithKline PLC, Bristol-Myers Squibb Company, Abbott Laboratories, AstraZeneca PLC, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., GT Medical Technologies Inc., Lupin Limited, Mylan NV, Sanofi SA, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Genetech Inc., Amneal Pharmaceuticals LLC, Emcure Pharmaceuticals Limited, Novocure Ltd., Arbour Pharmaceuticals LLC, Basilea Pharmaceuticals Ltd.
What Are the Major Trends Shaping the Adult Malignant Glioma Therapeutics Market?
Significant players in the adult malignant glioma therapeutics market are creating groundbreaking items, such as small molecule targeted degraders, to ensure reliable customer service. A small-molecule targeted degrader is a drug that employs small molecules to promote the degradation of specific proteins by concentrating on the protein of interest (POI) and an E3 ubiquitin ligase. For example, in February 2023, Beactica Therapeutics AB, a precision oncology company situated in Sweden, secured orphan drug designation approval from the U.S. Food and Drug Administration (FDA) for BEA-17 as a treatment for glioblastoma (GBM). BEA-17 is a small-molecule targeted degrader of the epigenetic enzyme LSD1 and its co-factor CoREST, both of which have been implicated in the development of various cancers, including GBM. BEA-17 operates by degrading LSD1 and CoREST, thereby reactivating tumor suppressor genes and inhibiting cancer cell growth.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/adult-malignant-glioma-therapeutics-global-market-report
What Are the Top Revenue-Generating Geographies in the Adult Malignant Glioma Therapeutics Market?
North America was the largest region in the adult malignant glioma therapeutics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adult malignant glioma therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Adult Malignant Glioma Therapeutics Market?
2. What is the CAGR expected in the Adult Malignant Glioma Therapeutics Market?
3. What Are the Key Innovations Transforming the Adult Malignant Glioma Therapeutics Industry?
4. Which Region Is Leading the Adult Malignant Glioma Therapeutics Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Incidence Of Brain Tumors Fuels Growth In The Adult Malignant Glioma Therapeutics Market: An Emerging Driver Transforming The Adult Malignant Glioma Therapeutics Market Landscape here
News-ID: 4021881 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Adult
Digital Adult Content Market Size Analysis by Application, Type, and Region: For …
USA, New Jersey- According to Market Research Intellect, the global Digital Adult Content market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
Due to rising internet accessibility, smartphone adoption, and a move toward subscription-based digital platforms, the market for digital adult content has grown steadily. …
Prominent Adult Entertainment Market Trend for 2025: AI-Driven Innovations In Ad …
"What Are the Projected Growth and Market Size Trends for the Adult Entertainment Market?
In recent times, the adult entertainment market has seen substantial expansion. The market size is set to increase from $65.95 billion in 2024 to $71.95 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.1%. The notable growth during the historic period is owed largely to a combination of factors. These include a wider acceptance…
Adult Day Care Services Market Overall Study Report 2024-2031 | Active Day/Senio …
Adult Day Care Services Market Trends Overview 2024-2031:
The latest report by Coherent Market Insights, titled "Adult Day Care Services Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2031," provides an in-depth analysis of the industry, offering valuable insights into the dynamics of the Adult Day Care Services market. The report features a detailed examination of competitive and regional trends, alongside recent advancements shaping the market landscape.
The report includes a…
Adult Diapers Market - A New Standard of Care: Transformative Diapers Redefining …
Newark, New Castle, USA: The "Adult Diapers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Adult Diapers Market: https://www.growthplusreports.com/report/adult-diapers-market/7749
This latest report researches the industry structure, sales, revenue,…
Adult Gastroenterology Associates Consolidates Offices
Adult Gastroenterology Associates (AGA), founded in 1987 and still the only independent gastroenterology practice in Tulsa, is combining all of their practices under one roof in the Richmond Plaza Building. The new location at 4200 E. Skelly Drive will be in the same building as the Tulsa Endoscopy Center, a partner company of AGA. The team members at AGA pride themselves on being completely centered on their patients and what…
Adult Toys Market
The global Adult Toys market is valued at 16200 million US$ in 2018 and will reach 34100 million US$ by the end of 2025, growing at a CAGR of 9.8% during 2019-2025.
The Market Insights Reports has published the obtainability of a new statistical data to its repository titled as, Adult Toys Market. The report provides useful insights into a wide range of business aspects such as pillars, features, sales strategies,…
